Gene Query: MGLL

Dataset Description Geneva Score
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 143.2
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 111.28
Silencing p300 in MCF7 cells to study expression and alternative splicing 104.12
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 90.73
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 86.35
Effect of BMP inhibition or stimulation of primary human keratinocytes 80.14
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 80.14
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 75.89
Differential analysis of gene regulation at transcript resolution by RNA-Seq 75.89
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 64.87
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 64.03
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 61.03
Differential gene expression in Jagged1 treated human dental pulp cells. 57.16
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 56.86
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 56.07
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 56.07
circRNA-sequencing 55.16
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 53.88
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 51.31
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 51.09
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 50.84
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 50.84
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 50.71
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 50.56
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 49.97
AR-independent prostate cancer is sustained through FGF signaling 49.49
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 48.82
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 48.39
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 48.39
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 48.06
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 46.05
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 45.48
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 45.11
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 44.5
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 44.25
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 44.11
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 44.01
SRSF2 mutations impair hematopoiesis and alter exon recognition 43.96
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 42.6
Chromatin-informed inference of transcriptional programs in gynecologic cancers 42.39
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 42.39
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 41.68
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 39.8
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 39.72
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 39.62
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 38.72
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 38.62
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 38.62
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 38.53
Control of prostate tumour growth by the long non-coding RNA GHSROS 38.46
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 38.43
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 38.43
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 38.15
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 38.15
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 38.12
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 37.37
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 37.37
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 37.35
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 37.27
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 37.18
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 37.18
Nonpregnant and term pregnant human myometrial tissues 37.13
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 37.13
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 36.99
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 36.94
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 36.87
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 36.75
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 36.26
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 36.04
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 35.9
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 35.9
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 35.84
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 35.47
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 35.03
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 34.78
Single-nucleotide-resolution mapping of HBV promoters using CAGE 34.65
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 34.52
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 34.5
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 34.14
Gene expression analysis of the impact of TDP-43 knockout in human cells. 33.93
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 33.9
Evolution of a transcriptional regulator from a transmembrane nucleoporin 33.87
RNA-seq in HepG2 and IMR90 cells 33.87
KLF6-dependent transcription in renal cancer cells 33.5
RNA-seq analysis of AML cells in response to ASLAN003 33.38
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 32.92
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 32.9
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 32.9
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 32.53
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 31.91
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 31.91
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 31.72
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 31.57
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 31.53
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 31.52
High level DNA repair gene expression in human ES cells 31.43
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 31.11
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 30.99
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 30.96
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 30.64
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 30.54
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 30.38
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 30.27
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 29.85
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 29.24
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 28.98
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 28.98
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 28.87
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 28.87
Irf9 function in immunity in mouse 28.63
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 28.63
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 28.63
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 28.42
Generation of KRAS signatures using immortalized isogenic lung cells. 28.36
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 28.35
BAF controls genome accessibility 28.25
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 27.93
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 27.88
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 27.79
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 27.79
RNA sequencing of BT142 and TS603 cell lines 27.72
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 27.72
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 27.56
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 27.19
Identifying the molecular mode of action of itraconazole in colorectal cancer 26.75
Rorc disruption in human FG pancreatic cancer cells 26.69
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 26.65
Nucleoporin-mediated regulation of cell identity genes 26.53
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 26.23
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 25.96
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 25.93
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 25.92
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 25.79
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 25.79
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 25.61
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 25.55
METTL3 promotes translation in human cancer cells 25.51
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 25.44
Generation of trichogenic adipose-derived stem cells by expression of three factors 25.3
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 25.19
Maturation of human iNSCs 25.11
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 24.92
Landscape of H3K4me3 in human CD19 cells 24.86
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 24.84
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 24.51
High-efficiency RNA-based reprogramming of human primary fibroblasts 24.46
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 24.32
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 24.21
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 23.74
RNA-seq of cells with TET1 knockout 23.61
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 23.38
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 23.35
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 23.32
CD86 regulates a pro-survival signal in myeloma cells 23.28
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 22.95
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 22.88
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 22.88
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 22.83
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 22.75
Tumor exosome integrins determine organotropic metastasis 22.66
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 22.53
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 22.29
Effect of nuclear IL-33 on gene expression 22.28
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 22.23
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 22.23
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 22.0
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 21.95
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 21.89
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 21.85
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 21.85
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 21.6
Crizotinib v. DMSO in SW480 cells 21.58
Inhibition of TNBC metastasis by Gpx1 21.55
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 21.54
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 21.46
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 21.43
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 21.37
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 21.18
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 21.05
RNA-seq of human aneuploid cell lines with Trisomy 21 20.91
Gene expression patterns define the hepatocyte-like cells derived by different strategies 20.85
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 20.85
Spliceosomal disruption of the non-canonical BAF complex in cancer 20.83
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 20.77
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 20.71
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 20.55
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 20.54
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 20.41
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 20.35
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 20.26
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 20.2
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 20.2
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 20.2
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 20.17
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 19.98
Functional role of SLIT2 and ROBO1 in trophoblasts 19.95
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 19.93
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 19.84
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 19.75
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 19.74
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 19.71
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 19.71
Gene expression analysis of dengue-infected cells 19.51
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 19.42
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 19.4
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 19.32
RNA-seq of MDA-MB-231 cells with TET1 knockout 19.27
X-Ray induced DNA-Hydroxymethylation changes 19.21
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 19.08
Gene expression profile of multiple myeloma cell lines treated with CB-5083 19.06
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 19.04
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 19.01
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 18.81
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 18.8
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 18.8
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 18.72
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 18.62
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 18.57
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 18.42
Total RNA sequencing of APC mutant and wt colonic organoids 18.41
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 18.29
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 18.26
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 18.24
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 18.21
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 18.05
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 18.05
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 18.02
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 17.96
Global analysis of alternative splicing regulated by RBM10 17.88
Generation and functional characterization of MDSC-like cells 17.85
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 17.83
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 17.78
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 17.74
Transcriptomes of human monocytes after ex vivo exposure to uric acid 17.68
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 17.61
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 17.61
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 17.44
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 17.4
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 17.3
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 17.26
RNA-seq of naive and primed ES cells 17.22
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 17.12
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 17.1
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 17.1
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 17.03
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 17.0
Regulation of highly expressed hCINAP on translatome 16.89
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 16.86
High-Throughput Kinetic Analysis of Fractional Killing 16.81
The cytokine environment influence on human skin-derived T cells 16.8
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 16.74
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 16.72
ARID1A regulates condensin II distribution and chromosomal partition 16.7
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 16.7
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 16.61
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 16.61
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 16.61
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 16.58
Trascriptome of thyroid cancer-induced macrophages 16.55
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 16.54
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 16.44
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 16.39
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 16.32
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 16.16
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 16.12
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 16.12
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 16.07
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 16.0
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 15.97
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 15.95
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 15.9
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 15.9
AUF-1 affected genes in human skin cells 15.9
Genome wide expression change in LCC2 and MCF-7 cells 15.79
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 15.78
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 15.71
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 15.71
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 15.67
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 15.6
Differentially expressed vascular development genes for iPSC-ECs from CDI 15.59
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 15.59
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 15.57
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 15.56
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 15.52
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 15.42
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 15.35
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 15.29
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 15.25
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 15.2
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 15.16
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 15.11
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 15.11
Splicing and epigenetic factors jointly regulate epidermal differentiation 15.08
Gene Expression Profiling of SPOP Knocked Down Cell 15.05
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 14.94
circRNA-sequencing 14.87
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 14.8
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 14.75
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 14.66
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 14.64
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 14.61
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 14.61
Persistence of stem cell metabolism in cancers as a failure of differentiation 14.6
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 14.55
Gene expression profile in breast cancer cell lines using RNA sequencing 14.49
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 14.47
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 14.42
Cajal bodies are linked to genome conformation 14.33
Cajal bodies are linked to genome conformation [RNA-Seq] 14.33
RNA-sequencing in immortalized human mammary epithelial cells 14.32
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 14.32
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 14.29
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 14.27
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 14.27
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 14.15
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 14.13
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 14.07
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 14.06
Analysis of transcriptional regulation by Myt1 and Myt1l 14.0
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 13.75
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 13.74
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 13.74
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 13.66
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 13.65
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 13.58
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 13.49
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 13.48
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 13.45
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 13.32
Transcriptome profiling of Normal and Cancerous Prostate Cells 13.29
Be1 and Be2 B cells are transcriptionally distinct 13.26
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 13.13
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 13.12
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 13.05
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 13.05
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 12.83
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 12.75
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 12.74
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 12.69
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 12.44
MicroRNA targetome analysis during HCMV infection 12.29
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 12.19
Effects of transcription on genome - nuclear lamina interactions 12.19
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 12.11
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 12.07
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 12.07
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 11.95
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 11.95
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 11.89
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 11.68
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 11.68
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 11.64
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 11.63
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 11.6
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 11.56
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 11.53
Effect of from Human Umbilical Vein Endothelial Cells 11.37
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 11.31
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 11.21
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 11.21
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 11.21
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 11.19
circNFIB suppresses lymphatic metastasis of pancreatic cancer 11.16
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 11.13
H1609088 Human RNA-Sequencing 11.1
ARID1A and ARID1B loss in HCT116 and TOV21G cells 10.91
Redifferentiation of expanded human islet β cells by inhibition of ARX 10.7
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 10.68
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 10.67
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 10.67
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 10.41
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 10.41
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 10.32
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 10.18
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 10.11
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 10.11
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 9.91
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 9.87
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 9.79
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 9.73
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 9.73
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 9.59
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 9.49
Transcriptome analysis of kidney organoids 9.48
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 9.45
Transciptomic profiling of human fetal lung samples 9.41
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 9.33
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 9.33
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 9.26
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 9.19
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 9.07
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 8.96
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 8.96
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 8.92
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 8.92
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 8.89
Metastasis in triple-negative breast cancer 8.89
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 8.76
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 8.74
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 8.72
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 8.7
Transcriptome analysis reveals differential splicing events in IPF lung tissue 8.68
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 8.65
Tpl-2 and MEK small molecule inhibitors 8.28
Tpl-2 small molecule project 8.28
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 8.28
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 7.67
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 7.67
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 7.57
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 7.43
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 7.1
Hepatocyte maturation 7.06
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 6.84
DAOY-Notch1/Notch2 knockout: transcriptome comparison 6.78
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 6.49
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 6.29
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 6.29
Metabolism as an early predictor of DPSCs aging 6.18
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 6.14
Leucegene: ALL sequencing 5.96
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 5.88
RNA-sequencing 5.81
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.8
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.8
Molecular Criteria for Defining the Naive Human Pluripotent State 5.76
Polarized B -cell functions 5.71
Proteomics identifies a marker signature of MAPKi resistance in melanoma 5.68
Hepatic transcriptome of pediatric hepatoblastoma. 5.49
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.46
Transcriptomes of oxLDL exposed trained monocytes 5.15
oxLDL exposed trained monocytes 5.15
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 5.1
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 5.1
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 5.1
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 4.95
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 4.95
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 4.79
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 4.65
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 4.65
Positively selected enhancer elements endow tumor cells with metastatic competence 4.62
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 4.14
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 3.99
mRNA sequencing of oropharyngeal cancer cell lines 3.94
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 3.9
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 3.9
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 3.88
RNA-seq of cancer cell lines treated with T-025 3.8
Gene expression analysis in response to hypoxic pathway inhibition 3.76
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 3.59
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 3.43
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 3.41
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 3.29
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 3.26
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 3.22
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 3.13
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 2.99
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 2.99
Molecular Mechanisms of Endothelial Hyperpermeability 2.86
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 2.76
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 2.74
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.71
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 2.71
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 2.71
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 2.66
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 2.63
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 2.6
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 2.56
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 2.55
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 2.48
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.07
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 2.06
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.02
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 1.9
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 1.77
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 1.77
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 1.6
Transcriptomic analysis of LSD1 1.58
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.43
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.23
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.21
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 1.2
Finding missing proteins from epigenetically manipulated human cells 1.2
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 1.11
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.01
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.01
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.0
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.0
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.68
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.66
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.66
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.59
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.58
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 0.44
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 0.43
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.39
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 0.38
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.3
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.27
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.25
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.05


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation